Identification Generic Name (1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile DrugBank Accession Number DB07465 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 Download  MOL SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile (DB07465) ×  Close Weight Average: 315.41  Monoisotopic: 315.194677059  Chemical Formula C 18 H 25 N 3 O 2 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Dipeptidyl peptidase 4 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Alpha amino acid amides Alternative Parents N-acylpiperidines  /  N-acylpyrrolidines  /  Tertiary carboxylic acid amides  /  Tertiary alcohols  /  Cyclic alcohols and derivatives  /  Nitriles  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organic oxides  /  Monoalkylamines  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 2 more Substituents Alcohol  /  Aliphatic heteropolycyclic compound  /  Alpha-amino acid amide  /  Amine  /  Azacycle  /  Carbonitrile  /  Carbonyl group  /  Carboxamide group  /  Cyclic alcohol  /  Hydrocarbon derivative  /  N-acyl-piperidine  /  N-acylpyrrolidine  /  Nitrile  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Piperidine  /  Primary aliphatic amine  /  Primary amine  /  Pyrrolidine  /  Tertiary alcohol  /  Tertiary carboxylic acid amide 
 
 
  show 16 more Molecular Framework Aliphatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key QGJUIPDUBHWZPV-YQBUGCKMSA-N InChI InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10-,11+,12-,13+,14+,15-,17+,18-/m1/s1 IUPAC Name (1S,3S,5S)-2-[(2S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile SMILES [H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)[C@]12C[C@@]3([H])C[C@]([H])(C[C@](O)(C3)C1)C2 References General References Not Available External Links PubChem Compound 11235729 PubChem Substance 99443936 ChemSpider 25027173 ZINC ZINC000100035546 PDBe Ligand BJM PDB Entries 3bjm Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 2.26 mg/mL ALOGPS logP 0.88 ALOGPS logP -0.08 Chemaxon logS -2.1 ALOGPS pKa (Strongest Acidic) 14.74 Chemaxon pKa (Strongest Basic) 7.9 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 90.35 Å 2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 83.99 m 3 ·mol -1 Chemaxon Polarizability 33.87 Å 3 Chemaxon Number of Rings 5 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9894 Blood Brain Barrier + 0.8823 Caco-2 permeable - 0.5446 P-glycoprotein substrate Substrate 0.5909 P-glycoprotein inhibitor I Non-inhibitor 0.696 P-glycoprotein inhibitor II Non-inhibitor 0.7875 Renal organic cation transporter Non-inhibitor 0.7903 CYP450 2C9 substrate Non-substrate 0.8618 CYP450 2D6 substrate Non-substrate 0.7519 CYP450 3A4 substrate Substrate 0.5944 CYP450 1A2 substrate Non-inhibitor 0.8448 CYP450 2C9 inhibitor Non-inhibitor 0.8017 CYP450 2D6 inhibitor Non-inhibitor 0.8198 CYP450 2C19 inhibitor Non-inhibitor 0.81 CYP450 3A4 inhibitor Non-inhibitor 0.8641 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9032 Ames test Non AMES toxic 0.7569 Carcinogenicity Non-carcinogens 0.9122 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.7529 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9912 hERG inhibition (predictor II) Non-inhibitor 0.832    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Dipeptidyl peptidase 4 Kind Protein Organism Humans Pharmacological action Unknown General Function Virus receptor activity Specific Function Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by bindi... Gene Name DPP4 Uniprot ID P27487 Uniprot Name Dipeptidyl peptidase 4 Molecular Weight 88277.935 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:22 / Updated at June 12, 2020 16:52 